1. Home
  2. Buyout

Category: Westlake Village BioPartners

Ex-Kleiner Perkins, Amgen execs seal $500m double fundraise targeting transformative life science companies

Westlake Village BioPartners has launched a pair of funds totalling $500m targeting life sciences companies with transformative human therapeutic technologies.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.